Abstract
A regimen consisting of two three-day courses of large doses of methotrexate with leukovorin rescue, followed by cytosine arabinoside infusion, given during days 1 and 7, and on day 15, vincristine, cyclophosphamide and predinisone with a time interval of 18–24 hr between vincristine and cyclophosphamide was tested. A total of 6 such cycles were used in 9 patients with histiocytic lymphoma who had not received prior chemotherapy. All nine responded, with a complete remission in 8. Prolonged disease-free survival of 48 or more months were seen in 3 of the complete responders. The efficacy of the cell-cycle agents, methotrexate and cytosine arabinoside was demonstrated since they were used as the initial phase of therapy, during which time a 78% response rate was observed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
